136 related articles for article (PubMed ID: 38530908)
1. Adiponectin Reduces Glomerular Endothelial Glycocalyx Disruption and Restores Glomerular Barrier Function in a Mouse Model of Type 2 Diabetes.
Fawaz S; Martin Alonso A; Qiu Y; Ramnath R; Stowell-Connolly H; Gamez M; May C; Down C; Coward RJ; Butler MJ; Welsh GI; Satchell SC; Foster RR
Diabetes; 2024 Jun; 73(6):964-976. PubMed ID: 38530908
[TBL] [Abstract][Full Text] [Related]
2. Endothelial glycocalyx restoration by growth factors in diabetic nephropathy.
Desideri S; Onions KL; Baker SL; Gamez M; El Hegni E Hussien H; Russell A; Satchell SC; Foster RR
Biorheology; 2019; 56(2-3):163-179. PubMed ID: 31156139
[TBL] [Abstract][Full Text] [Related]
3. Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease.
Ramnath RD; Butler MJ; Newman G; Desideri S; Russell A; Lay AC; Neal CR; Qiu Y; Fawaz S; Onions KL; Gamez M; Crompton M; Michie C; Finch N; Coward RJ; Welsh GI; Foster RR; Satchell SC
Kidney Int; 2020 May; 97(5):951-965. PubMed ID: 32037077
[TBL] [Abstract][Full Text] [Related]
4. Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice.
Qiu Y; Buffonge S; Ramnath R; Jenner S; Fawaz S; Arkill KP; Neal C; Verkade P; White SJ; Hezzell M; Salmon AHJ; Suleiman MS; Welsh GI; Foster RR; Madeddu P; Satchell SC
Diabetologia; 2022 May; 65(5):879-894. PubMed ID: 35211778
[TBL] [Abstract][Full Text] [Related]
5. Low dose cadmium inhibits syndecan-4 expression in glycocalyx of glomerular endothelial cells.
Meng X; Xie S; Liu J; Lv B; Huang X; Liu Q; Wang X; Malashicheva A; Liu J
J Appl Toxicol; 2024 Jun; 44(6):908-918. PubMed ID: 38396353
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor α: a contributor to endothelial cell glycocalyx dysfunction.
Ramnath R; Foster RR; Qiu Y; Cope G; Butler MJ; Salmon AH; Mathieson PW; Coward RJ; Welsh GI; Satchell SC
FASEB J; 2014 Nov; 28(11):4686-99. PubMed ID: 25122554
[TBL] [Abstract][Full Text] [Related]
7. VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy.
Onions KL; Gamez M; Buckner NR; Baker SL; Betteridge KB; Desideri S; Dallyn BP; Ramnath RD; Neal CR; Farmer LK; Mathieson PW; Gnudi L; Alitalo K; Bates DO; Salmon AHJ; Welsh GI; Satchell SC; Foster RR
Diabetes; 2019 Jan; 68(1):172-187. PubMed ID: 30389746
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyx.
Crompton M; Ferguson JK; Ramnath RD; Onions KL; Ogier AS; Gamez M; Down CJ; Skinner L; Wong KH; Dixon LK; Sutak J; Harper SJ; Pontrelli P; Gesualdo L; Heerspink HL; Toto RD; Welsh GI; Foster RR; Satchell SC; Butler MJ
JCI Insight; 2023 Mar; 8(5):. PubMed ID: 36749631
[TBL] [Abstract][Full Text] [Related]
9. Roles of glomerular endothelial hyaluronan in the development of proteinuria.
Asai A; Hatayama N; Kamiya K; Yamauchi M; Kinashi H; Yamaguchi M; Katsuno T; Nobata H; Watanabe K; Wakatsuki A; Aten J; Maruyama S; Ishimoto T; Hirai S; Naito M; Ito Y
Physiol Rep; 2021 Sep; 9(17):e15019. PubMed ID: 34472715
[TBL] [Abstract][Full Text] [Related]
10. Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway.
Yang S; Ma C; Wu H; Zhang H; Yuan F; Yang G; Yang Q; Jia L; Liang Z; Kang L
Pharmacol Res; 2020 Mar; 153():104678. PubMed ID: 32014572
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone induces albuminuria via matrix metalloproteinase-dependent damage of the endothelial glycocalyx.
Butler MJ; Ramnath R; Kadoya H; Desposito D; Riquier-Brison A; Ferguson JK; Onions KL; Ogier AS; ElHegni H; Coward RJ; Welsh GI; Foster RR; Peti-Peterdi J; Satchell SC
Kidney Int; 2019 Jan; 95(1):94-107. PubMed ID: 30389198
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.
Peng H; Luo P; Li Y; Wang C; Liu X; Ye Z; Li C; Lou T
PLoS One; 2013; 8(11):e80009. PubMed ID: 24244596
[TBL] [Abstract][Full Text] [Related]
13. Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy.
Oltean S; Qiu Y; Ferguson JK; Stevens M; Neal C; Russell A; Kaura A; Arkill KP; Harris K; Symonds C; Lacey K; Wijeyaratne L; Gammons M; Wylie E; Hulse RP; Alsop C; Cope G; Damodaran G; Betteridge KB; Ramnath R; Satchell SC; Foster RR; Ballmer-Hofer K; Donaldson LF; Barratt J; Baelde HJ; Harper SJ; Bates DO; Salmon AH
J Am Soc Nephrol; 2015 Aug; 26(8):1889-904. PubMed ID: 25542969
[TBL] [Abstract][Full Text] [Related]
14. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
Gamez M; Elhegni HE; Fawaz S; Ho KH; Campbell NW; Copland DA; Onions KL; Butler MJ; Wasson EJ; Crompton M; Ramnath RD; Qiu Y; Yamaguchi Y; Arkill KP; Bates DO; Turnbull JE; Zubkova OV; Welsh GI; Atan D; Satchell SC; Foster RR
Cardiovasc Diabetol; 2024 Feb; 23(1):50. PubMed ID: 38302978
[TBL] [Abstract][Full Text] [Related]
15. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of TGF-β Inducible microRNA-143 in Zebrafish Leads to Impairment of the Glomerular Filtration Barrier by Targeting Proteoglycans.
Müller-Deile J; Gellrich F; Schenk H; Schroder P; Nyström J; Lorenzen J; Haller H; Schiffer M
Cell Physiol Biochem; 2016; 40(5):819-830. PubMed ID: 27941332
[TBL] [Abstract][Full Text] [Related]
17. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.
Qi H; Casalena G; Shi S; Yu L; Ebefors K; Sun Y; Zhang W; D'Agati V; Schlondorff D; Haraldsson B; Böttinger E; Daehn I
Diabetes; 2017 Mar; 66(3):763-778. PubMed ID: 27899487
[TBL] [Abstract][Full Text] [Related]
18. Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.
Boels MGS; Koudijs A; Avramut MC; Sol WMPJ; Wang G; van Oeveren-Rietdijk AM; van Zonneveld AJ; de Boer HC; van der Vlag J; van Kooten C; Eulberg D; van den Berg BM; IJpelaar DHT; Rabelink TJ
Am J Pathol; 2017 Nov; 187(11):2430-2440. PubMed ID: 28837800
[TBL] [Abstract][Full Text] [Related]
19. Fasting mimicking diet in diabetic mice partially preserves glomerular endothelial glycocalyx coverage, without changing the diabetic metabolic environment.
van der Velden AIM; Koudijs A; Kooijman S; Rietjens RGJ; Sol WMPJ; Avramut MC; Wang G; Rensen PCN; Rabelink TJ; van der Vlag J; van den Berg BM
Am J Physiol Renal Physiol; 2024 May; 326(5):F681-F693. PubMed ID: 38205540
[TBL] [Abstract][Full Text] [Related]
20. Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-κB signaling in diabetic kidney disease.
Cui S; Chen X; Li J; Wang W; Meng D; Zhu S; Shen S
Cell Commun Signal; 2024 Mar; 22(1):191. PubMed ID: 38528533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
